Studien
- Prüfplan J3R-MC-YDAF (läuft bereits)
A Phase 3 Radomized, Double-Blind, Phlacebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly eloralintide versus Placebo in Adult Participants with Obesity or Overweight and Type 2 Diabetes
Gesponsert durch Eli Lilly and Company
- Prüfplan M26-015 (startet bald)
A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults with Obesity or Overweight with Weight-related Comorbidities
Gesponsert durch AbbVie Deutschland GmbH & Co. KG
